Imaging liver metastases of colorectal cancer patients with radiolabelled bevacizumab: Lack of correlation with VEGF-A expression
- 1 September 2008
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 44 (13) , 1835-1840
- https://doi.org/10.1016/j.ejca.2008.05.026
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Specific imaging of VEGF‐A expression with radiolabeled anti‐VEGF monoclonal antibodyInternational Journal of Cancer, 2008
- In Vivo VEGF Imaging with Radiolabeled Bevacizumab in a Human Ovarian Tumor XenograftJournal of Nuclear Medicine, 2007
- Development of the tumor vascular bed in response to hypoxia‐induced VEGF‐A differs from that in tumors with constitutive VEGF‐A expressionInternational Journal of Cancer, 2006
- Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2004
- Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNature Reviews Drug Discovery, 2004
- Influences of the p53 Status on Hypoxia-induced Gene ExpressionJournal of Radiation Research, 2004
- EORTC Receptor and Biomarker Study Group Report: A Sandwich Enzyme-Linked Immunosorbent Assay for Vascular Endothelial Growth Factor in Blood and Tumor Tissue ExtractsThe International Journal of Biological Markers, 2000
- The Biology of Vascular Endothelial Growth FactorEndocrine Reviews, 1997
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992